Skip to Content

WATSON 3450 30 mg (Morphine Sulfate Extended Release 30 mg)

Pill with imprint WATSON 3450 30 mg is Purple / White, Capsule-shape and has been identified as Morphine Sulfate Extended Release 30 mg. It is supplied by Watson Laboratories, Inc..

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 3450 30 mg

Morphine sulfate extended release 30 mg WATSON 3450 30 mg

Morphine Sulfate Extended Release

WATSON 3450 30 mg
30 mg
Purple / White
16.00 mm
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
Inactive Ingredients
corn starch, diethyl phthalate, ethylcelluloses, polyethylene glycol 6000, sucrose, povidone k30, magnesium silicate, ferric oxide black, gelatin, propylene glycol, titanium dioxide, FD&C Blue No. 1, FD&C Red No. 3, hypromellose 2910 (5 mPa.s), methacrylic acid - ethyl acrylate copolymer (1:1) type a

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.